Treatment of diffuse alveolar hemorrhage secondary to lupus erythematosus with recombinant activated factor VII administered with a jet nebulizer

Diffuse alveolar hemorrhage (DAH) is a serious pulmonary complication in patients with autoimmune diseases who are undergoing chemotherapy or have had hematopoietic stem cell transplantation. The use of recombinant factor VIIa (rFVIIa) to treat the acute phase of DAH by endobronchial bronchoscopy ha...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Intensive Care
Egile Nagusiak: Esper, Raúl Carrillo, Estrada, Isis Espinoza de los Monteros, de la Torre León, Teresa, Gutiérrez, Agustín Omar Rosales, López, Jorge Arturo Nava
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2014
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4336265/
https://ncbi.nlm.nih.gov/pubmed/25705408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40560-014-0047-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak